Genelux Corp. (GNLX)
2.67
+0.17
(+6.80%)
USD |
NASDAQ |
Apr 30, 16:00
2.66
-0.01
(-0.37%)
After-Hours: 20:00
Genelux Market Cap : 119.63M for April 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcutis Biotherapeutics, Inc. | 2.880B |
| MBX Biosciences, Inc. | 1.436B |
| ACADIA Pharmaceuticals, Inc. | 3.828B |
| Agenus, Inc. | 150.14M |
| Alnylam Pharmaceuticals, Inc. | 41.29B |
Market Cap Related Metrics
| PS Ratio | 12388.09 |
| Price to Book Value | 10.36 |
| Price | 2.67 |
| Earnings Yield | -32.43% |